Sökning: onr:"swepub:oai:DiVA.org:uu-453572" >
Risk factors for re...
-
Pisano, F.Univ Studies Turin, Citta Salute & Sci Torino, Turin, Italy.;Univ Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spain.
(författare)
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients
- Artikel/kapitelEngelska2021
Förlag, utgivningsår, omfång ...
-
ENE EDICIONES SL,2021
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-453572
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-453572URI
-
https://doi.org/10.1016/j.acuro.2020.08.016DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Introduction and objectives: The goals of transurethral resection of a bladder tumor (TUR) are to completely resect the lesions and to make a correct diagnosis in order to adequately stage the patient. It is well known that the presence of detrusor muscle in the specimen is a prerequisite to minimize the risk of under staging. Persistent disease after resection of bladder tumors is not uncommon and is the reason why the European Guidelines recommended a re-TUR for all T1 tumors. It was recently published that when there is muscle in the specimen, re-TUR does not influence progression or cancer specific survival. We present here the patient and tumor factors that may influence the presence of residual disease at re-TUR.Material and methods: In our retrospective cohort of 2451 primary T1G3 patients initially treated with BCG, pathology results for 934 patients (38.1%) who underwent re-TUR are available. 74% had multifocal tumors, 20% of tumors were more than 3 cm in diameter and 26% had concomitant CIS. In this subgroup of patients who underwent re-TUR, there was no residual disease in 267 patients (29%) and residual disease in 667 patients (71%): Ta in 378 (40%) and T1 in 289 (31%) patients. Age, gender, tumor status (primary/recurrent), previous intravesical therapy, tumor size, tumor multi-focality, presence of concomitant CIS, and muscle in the specimen were analyzed in order to evaluate risk factors of residual disease at re-TUR, both in univariate analyses and multivariate logistic regressions.Results: The following were not risk factors for residual disease: age, gender, tumor status and previous intravesical chemotherapy. The following were univariate risk factors for presence of residual disease: no muscle in TUR, multiple tumors, tumors >= 3 cm, and presence of concomitant CIS. Due to the correlation between tumor multi-focality and tumor size, the multivariate model retained either the number of tumors or the tumor diameter (but not both), p < 0.001. The presence of muscle in the specimen was no longer significant, while the presence of CIS only remained significant in the model with tumor size, p < 0.001.Conclusions: The most significant factors for a higher risk of residual disease at re-TUR in T1G3 patients are multifocal tumors and tumors more than 3 cm. Patients with concomitant CIS and those without muscle in the specimen also have a higher risk of residual disease.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Gontero, P.Univ Studies Turin, Citta Salute & Sci Torino, Turin, Italy.
(författare)
-
Sylvester, R.EORTC Headquarters, Dept Biostat, Brussels, Belgium.
(författare)
-
Joniau, S.Univ Hosp Leuven, Dept Urol, Oncol & Reconstruct Urol, Leuven, Belgium.
(författare)
-
Serretta, VUniv Palermo, Dept Surg Oncol & Stomatol Sci, Palermo, Italy.
(författare)
-
Larre, S.Univ Oxford, John Radcliffe Hosp, Dept Surg Sci, Oxford, England.
(författare)
-
Di Stasi, S.Policlin Tor Vergata Univ Rome, Rome, Italy.
(författare)
-
van Rhijn, B.Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands.
(författare)
-
Witjes, A.Radboud Univ Nijmegen, Dept Urol, Med Ctr, Nijmegen, Netherlands.
(författare)
-
Grotenhuis, A.Radboud Univ Nijmegen, Dept Urol, Med Ctr, Nijmegen, Netherlands.
(författare)
-
Colombo, R.Univ Vita Salute, Dipartimento Urol, Osped S Raffaele, Milan, Italy.
(författare)
-
Briganti, A.Univ Vita Salute, Dipartimento Urol, Osped S Raffaele, Milan, Italy.
(författare)
-
Babjuk, M.Univ Praha, Motol Hosp, Dept Urol, Prague, Czech Republic.
(författare)
-
Soukup, VUniv Praha, Motol Hosp, Dept Urol, Prague, Czech Republic.
(författare)
-
Malmström, Per-UnoUppsala universitet,Urologkirurgi(Swepub:uu)perunoms
(författare)
-
Irani, J.Hosp Bicetre, Dept Urol, Le Kremlin Bicetre, France.
(författare)
-
Malats, N.Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain.
(författare)
-
Baniel, J.Rabin Med Ctr, Dept Urol, Tel Aviv, Israel.
(författare)
-
Mano, R.Rabin Med Ctr, Dept Urol, Tel Aviv, Israel.
(författare)
-
Cai, T.Santa Chiara Hosp, Dept Urol, Trento, Italy.
(författare)
-
Cha, E.Mem Sloan Kettering Canc Ctr, Dept Urol, 1275 York Ave, New York, NY 10021 USA.
(författare)
-
Ardelt, P.Univ Hosp Basel, Urol Univ Clin Basel Liestal, Basel, Switzerland.
(författare)
-
Varkarakis, J.Univ Athens, Sismanoglio Hosp, Dept Urol, Athens, Greece.
(författare)
-
Bartoletti, R.Univ Florence, Dept Expt & Clin Med, Florence, Italy.
(författare)
-
Dalbagni, G.Mem Sloan Kettering Canc Ctr, Dept Urol, 1275 York Ave, New York, NY 10021 USA.
(författare)
-
Shariat, S. F.Med Univ Vienna, Dept Urol, A-1190 Vienna, Austria.;Cochin Hosp, Dept Urol, Paris, France.
(författare)
-
Xylinas, E.Mayo Clin, Dept Urol, Rochester, MN USA.
(författare)
-
Karnes, R. J.Mayo Clin, Dept Urol, Rochester, MN USA.
(författare)
-
Palou, J.Univ Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spain.
(författare)
-
Univ Studies Turin, Citta Salute & Sci Torino, Turin, Italy.;Univ Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spain.Univ Studies Turin, Citta Salute & Sci Torino, Turin, Italy.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Actas Urológicas Españolas: ENE EDICIONES SL45:6, s. 473-4780210-48061699-7980
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Pisano, F.
-
Gontero, P.
-
Sylvester, R.
-
Joniau, S.
-
Serretta, V
-
Larre, S.
-
visa fler...
-
Di Stasi, S.
-
van Rhijn, B.
-
Witjes, A.
-
Grotenhuis, A.
-
Colombo, R.
-
Briganti, A.
-
Babjuk, M.
-
Soukup, V
-
Malmström, Per-U ...
-
Irani, J.
-
Malats, N.
-
Baniel, J.
-
Mano, R.
-
Cai, T.
-
Cha, E.
-
Ardelt, P.
-
Varkarakis, J.
-
Bartoletti, R.
-
Dalbagni, G.
-
Shariat, S. F.
-
Xylinas, E.
-
Karnes, R. J.
-
Palou, J.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
- Artiklar i publikationen
-
Actas Urológicas ...
- Av lärosätet
-
Uppsala universitet